201 results
Page 2 of 11
S-8
EX-23.1
r8h79g tig9g84h
21 Jun 23
Registration of securities for employees
5:16pm
S-8
EX-4.5
j7w9p6d
21 Jun 23
Registration of securities for employees
5:16pm
DEFA14A
ju7w6j gx
7 Jun 23
Additional proxy soliciting materials
5:00pm
DEFA14A
t5b6i2kr0ol
30 May 23
Additional proxy soliciting materials
7:48am
8-K
m7y9ce7vsjv rg
26 May 23
Submission of Matters to a Vote of Security Holders
7:37am
DEFA14A
6yg0lfnr lcekak
12 May 23
Additional proxy soliciting materials
5:00pm
8-K
EX-99.1
fevbn k0zihm8vj9
10 May 23
Moleculin Provides Update on Ongoing Clinical Trials and Outlines Expected Upcoming Milestones
4:07pm
8-K
EX-99.1
4l2q4lrvqtl884ij5
15 Dec 22
Preliminary efficacy updated to 80% overall response rate (ORR) demonstrated in single agent AML trial following database lock
8:37am
8-K
EX-99.1
d033r9ad7vhpuiz5o08v
10 Nov 22
Moleculin Reports Third Quarter 2022 Financial Results and Provides Pipeline Update
4:11pm
S-8
EX-23.1
0jkr61s9bahw9
19 Jul 22
Registration of securities for employees
5:18pm
S-8
EX-4.5
4ocgwax
19 Jul 22
Registration of securities for employees
5:18pm
8-K
gzzpgiifeje 0vru82
31 May 22
Submission of Matters to a Vote of Security Holders
4:35pm
8-K
EX-99.1
jxseljt tszwfu
5 May 22
Regulation FD Disclosure
8:15am